Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPMI
āļāļ·āđāļāļāļĢāļīāļĐāļąāļPicard Medical Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 29, 2025
āļāļĩāļāļĩāđāļSchnegelsberg (Patrick N.J)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ75
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļAug 29
āļāļĩāđāļāļĒāļđāđ1992 E. Silverlake Rd.
āđāļĄāļ·āļāļTUCSON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX â NASDAQ Basic Amex
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ85713
āđāļāļĢāļĻāļąāļāļāđ15203080796
āđāļ§āđāļāđāļāļāđ
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPMI
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļAug 29, 2025
āļāļĩāļāļĩāđāļSchnegelsberg (Patrick N.J)
Mr. Matt Schuster
Chief Operating Officer
Dr. Richard A. Fang, Ph.D.
Dr. Richard A. Fang, Ph.D.
Executive Chairman of the Board, Interim Chief Executive Officer
Executive Chairman of the Board, Interim Chief Executive Officer
Mr. Sam Van
Independent Director
Mr. George Ye
Independent Director
Ms. Georgina Smith
Chief Accounting Officer
Mr. Matt Schuster
Chief Operating Officer
Dr. Richard A. Fang, Ph.D.
Dr. Richard A. Fang, Ph.D.
Executive Chairman of the Board, Interim Chief Executive Officer
Executive Chairman of the Board, Interim Chief Executive Officer
Mr. Sam Van
Independent Director
Mr. George Ye
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Matt Schuster
Chief Operating Officer
Dr. Richard A. Fang, Ph.D.
Dr. Richard A. Fang, Ph.D.
Executive Chairman of the Board, Interim Chief Executive Officer
Executive Chairman of the Board, Interim Chief Executive Officer
Mr. Sam Van
Independent Director
Mr. George Ye
Independent Director
Ms. Georgina Smith
Chief Accounting Officer